Biology of Blood and Marrow Transplantation
Volume 15, Issue 8 , Pages 948-955 , August 2009

Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Myelodysplastic Syndrome: A Single-Center Experience

  • Suhag H. Parikh

      Affiliations

    • Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationCorrespondence and reprint requests: Suhag H. Parikh, MD, Pediatric Blood and Marrow Transplant Program, Duke University Medical Center, 1400 Morreene Road, Durham, NC 27705.
    • ,
  • Adam Mendizabal

      Affiliations

    • Emmes Corporation, Rockville, Maryland
    • ,
  • Paul L. Martin

      Affiliations

    • Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina
    • ,
  • Vinod K. Prasad

      Affiliations

    • Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina
    • ,
  • Paul Szabolcs

      Affiliations

    • Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina
    • ,
  • Timothy A. Driscoll

      Affiliations

    • Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina
    • ,
  • Joanne Kurtzberg

      Affiliations

    • Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina

Received 10 February 2009 ,Accepted 12 April 2009.

References 

  1. Anderson J. Allogeneic transplantation for myelodysplastic and myeloproliferative disorders. In:  Blume KG,  Forman SJ,  Appelbaum FR editor. Thomas' Hematopoietic Cell Transplantation. Malden, MA: Blackwell Publishing; 2004;p. 1084–1095
  2. Hamblin T. Epidemiology of the myelodysplastic syndromes. In:  Bennett J editors. The Myelodysplastic Syndromes. New York: Marcel Dekker; 2002;p. 15–27
  3. Olney HJ, Le Beau MM. The cytogenetics of myelodysplastic syndromes. Best Pract Res Clin Haematol. 2001;14:479–495
  4. Vallespi T, Imbert M, Mecucci C, Preudhomme C, Fenaux P. Diagnosis, classification, and cytogenetics of myelodysplastic syndromes. Haematologica. 1998;83:258–275
  5. Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR. A population-based study of childhood myelodysplastic syndrome in British Columbia. Canada. Br J Haematol. 1999;106:1027–1032
  6. Hasle H, Kerndrup G, Jacobsen B. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia. 1995;9:1569–1572
  7. Hasle H, Baumann I, Bergstrasser E, et al. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia. 2004;18:2008–2014
  8. Mantadakis E, Shannon KM, Singer DA, et al. Transient monosomy 7: a case series in children and review of literature. Cancer. 1999;85:2655–2661
  9. Hasle H, Kerndrup G, Yssing M, et al. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia. 1996;10:1269–1273
  10. Niemeyer CM, Kratz CP. Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options. Br J Haematol. 2008;140:610–624
  11. Woods WG, Barnard DR, Alonzo TA, et al. Prospective study of 90 children requiring treatment for juvenile myelomonocytic leukemia or myelodysplastic syndrome: a report from the Children's Cancer Group. J Clin. Oncol. 2002;20:434–440
  12. Kardos G, Baumann I, Passmore SJ, et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood. 2003;102:1997–2003
  13. Yusuf U, Frangoul HA, Gooley TA, et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transplant. 2004;33:805–814
  14. Trobaugh-Lotrario AD, Kletzel M, Quinones RR, et al. Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT). Bone Marrow Transplant. 2004;35:143
  15. Locatelli F, Nollke P, Zecca M, et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood. 2005;105:410–419
  16. Bone Marrow Transplants: Despite Recruitment Successes, National Program May Be Underutilized. Washington, DC: General Accounting Office (GAO-03-182); 2002;
  17. Locatelli F, Moreno-Madureira A, Teira P, et al. Encoraging results after alternative donor transplantation for myelodysplastic syndrome. Blood (ASH Annu Meet Abstr). 2008;112:684;(#1964)
  18. Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008;112:4318–4327
  19. Hasle H, Niemeyer C, Chessells J, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia. 2003;17:277–282
  20. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–828
  21. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2005;11:945
  22. Gooley T, Leisenring W, Crowley J, Storer B. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706
  23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  24. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–748
  25. Cox D. Regression models and life-tables. J R Stat Soc Series B (Methodol). 1972;34:187–220
  26. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med. 1997;337:373–381
  27. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–1577
  28. Castro-Malaspina H, Harris RE, Gajewski J, et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood. 2002;99:1943–1951
  29. Eapen M, Rubinstein P, Zhang M-J, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369:1947–1954
  30. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97:2962–2971
  31. Woodard P, Barfield R, Hale GA, et al. Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome. Pediatr Blood Cancer. 2006;47:931–935
  32. Strahm B, Locatelli F, Bader P, et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant. 2007;40:329–333

 Financial disclosure: See Acknowledgments on page 955.

PII: S1083-8791(09)00208-0

doi: 10.1016/j.bbmt.2009.04.010

Biology of Blood and Marrow Transplantation
Volume 15, Issue 8 , Pages 948-955 , August 2009

Article Tools

* Image Usage & Resolution